OHB’s Order Book Under the Microscope: Sentinel-3, Hera and the 12 November Verdict
Published on 11/11/2026 at 16:02 | Editorial boerse-global.de
A EUR 554 million development contract is a solid foundation. Whether it becomes a broader growth story depends on how many of the projects now under discussion turn into binding orders — and on what the numbers say next month.
The European Space Agency's decision to award OHB System AG the development of the next generation of Copernicus Sentinel-3 topography satellites gives investors something the sector rarely offers: a hard number. The contract, announced on 4 November, carries a volume of more than EUR 554 million, with an option for a second satellite attached. That confirmed order, rather than any pipeline speculation, is the anchor for the current investment case.
Berenberg's Michael Filatov reinforced that view yesterday, restating a buy rating and a price target of 358 euros. He expects strong order intake in the second half of 2026 and sees the Sentinel award as supporting that thesis. He also flagged a potential decision on SATCOMBw Stage 4 as a further theme worth watching. Where his argument leans on the contract already signed, it carries weight; where it anticipates decisions yet to be made, it remains a forecast.
The distinction matters because not all good news is created equal. A awarded development contract, a contractual option and a memorandum of understanding to explore cooperation each sit at a different point on the spectrum of certainty. Investors weighing OHB's growth prospects should price those opportunities according to their contractual status rather than treating every announcement as equivalent.
Hera delivers a technical marker
On the operational side, OHB reported that the Hera probe it developed for ESA transmitted its first image of the Didymos asteroid system on Friday. The company also reported successful dress rehearsals for the Juventas and Milani CubeSats. It is a tangible sign that a demanding programme is progressing in practice — the kind of execution evidence that gives technical credibility to the wider project portfolio.
Should investors sell immediately? Or is it worth buying OHB SE?
That credibility only feeds through to the valuation, however, if OHB keeps delivering on subsequent programmes with the same reliability. The link between development and execution is where confidence should be anchored.
Sell-side coverage is not uniform on where the shares should trade. Jefferies had already left OHB at buy with a target of 280 euros on 29 October, ahead of the quarterly figures. Two positive ratings, two markedly different target prices: the gap itself shows how much room even bullish analysts leave themselves on valuation. For investors, the reasoning behind a target is more instructive than the number attached to it.
What would broaden the base
Two further developments could thicken the growth narrative. The first is exercise of the Sentinel-3 satellite option, which would convert a possibility into booked business. The second is the memorandum of understanding signed with Astroscale Holdings Inc. on 28 October, under which the two companies will examine cooperation in space safety, space situational awareness and in-orbit services.
Should that review produce concrete joint ventures, the agreement would move beyond a search for opportunities and become a genuine additional support for the positive case — provided the scope and binding nature of any projects are specified. Until then, the contracted business carries the thesis.
The risk runs in the opposite direction. Anyone following Filatov's view is effectively betting on further strong order intake; if additional orders arrive more slowly than expected, the positive case weakens. The existing ESA contract would retain its value, but the anticipated extra growth impulse would be smaller. The trap is valuing possible projects as though they were firm orders. A more cautious reading is warranted when forthcoming announcements consist mainly of reviews and intentions; binding contracts with clearly stated volumes would be far more telling.
The 12 November scorecard
OHB has scheduled publication of its results for the first nine months of 2026, together with a results presentation, for 12 November 2026. That date is the near-term test. A more favourable assessment of the company would be justified if the figures convincingly underpin the operating performance — and the focus should be on how order intake, project progress and earnings reinforce one another. A development in which those three elements support each other would give the positive view a broader footing than a single large contract can provide.
The next concrete catalyst, then, is either a further order announcement or exercise of the existing satellite option. Progress with Astroscale could also become relevant if it moves beyond the examination of possibilities. What counts for the OHB decision is less the number of positive headlines than their commercial bindingness. The ESA mandate provides a dependable starting point; whether a more fully secured growth story emerges from it will be settled by additional firm commitments — and by the execution visible in next month's numbers.
Ad
OHB SE Stock: New Analysis - 11 November
Fresh OHB SE information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
